Injection of sclerosing agent lauromacrogol for the treatment of lymph leakage：clinical analysis of 15 cases
10.3969/j.issn.1008-794X.2014.09.006
- VernacularTitle:硬化剂聚桂醇注射液治疗淋巴漏15例临床分析
- Author:
Huipeng ZHU
;
Yilin ZHOU
;
Zhongyou XU
;
Jiagen LI
;
Daye JIN
;
Jibo MA
- Publication Type:Journal Article
- Keywords:
lymph leakage;
B-ultrasound;
injection;
lauromacrogol
- From:Journal of Interventional Radiology
2014;(9):767-768
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the clinical effect of ultrasound - guided sclerosing agent lauromacrogol injection in treating lymph leakage. Methods A total of 31 patients with postoperative lymph leakage were selected for this study. Of the 31 patients, successful conservative oppression treatment was accomplished in 16, and lauromacrogol injection had to be carried out in 15 as conservative oppression treatment failed. The patients were followed up and the results were analyzed. Results In 15 patients receiving lauromacrogol injection treatment, complete cure of lymph leak was obtained in 14 with a success rate of 93.33%. Among the 14 cases, the second lauromacrogol injection was employed in 3 at one week after the first injection. Infection occurred in another case one day after the injection , which was cured after dressing change for 15 days. Conclusion For the treatment of lymph leakage, ultrasound-guided sclerosing agent lauromacrogol injection is effective and safe.
